C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/42 (2006.01) A61K 31/505 (2006.01) A61K 31/506 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 403/06 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01)
Patent
CA 2495880
This relates to novel pyrimidine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
Cette invention concerne des nouveaux dérivés de pyrimidine, des compositions pharmaceutiques renfermant lesdits dérivés et leur utilisation dans le traitement de maladies, singulièrement de la douleur, lesquelles maladies sont dues directement ou indirectement à une augmentation ou une diminution de l'activité du récepteur des cannabinoïdes.
Eatherton Andrew John
Giblin Gerard Martin Paul
Green Richard Howard
Mitchell William Leonard
Naylor Alan
Glaxo Group Limited
Gowling Lafleur Henderson Llp
LandOfFree
Pyrimidine derivatives and their use as cb2 modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine derivatives and their use as cb2 modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives and their use as cb2 modulators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2071950